EICHOR
● Completed
Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
Condition: Sickle Cell Disease · Sponsor: Claudia R. Morris
About this study
The trial is designed to test intravenous (IV) arginine therapy in children with sickle cell disease (SCD) and vaso-occlusive painful episodes (VOE) to further knowledge on efficacy and safety of this orphan drug.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (10)
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| UCSF Benioff Children's Hospital | San Francisco, California, United States | — |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | — |
| Children's Healthcare of Atlanta at Hughes Spalding | Atlanta, Georgia, United States | — |
| Children's Healthcare of Atlanta at Egleston | Atlanta, Georgia, United States | — |
| Washington University/St. Louis Children's Hospital | St Louis, Missouri, United States | — |
| Nationwide Children's Hospital | Columbus, Ohio, United States | — |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | — |
| Texas Children's Hospital/Baylor College of Medicine | Houston, Texas, United States | — |
| Medical College of Wisconsin/Wisconsin Children's Hospital | Wauwatosa, Wisconsin, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.